Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series

Abstract Chronic insomnia is common in patients with Parkinson’s disease. There are limited data to guide its treatment in this patient population, especially in regards to non-pharmacologic interventions, some of which are highly effective in the non-Parkinson’s disease population. The aim of this...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Meghan Humbert, James Findley, Maria Hernandez-Con, Lana M. Chahine
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/29586d4ccc924b56b3918d360dea53f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:29586d4ccc924b56b3918d360dea53f4
record_format	dspace
spelling	oai:doaj.org-article:29586d4ccc924b56b3918d360dea53f42021-12-02T15:10:26ZCognitive behavioral therapy for insomnia in Parkinson’s disease: a case series10.1038/s41531-017-0027-z2373-8057https://doaj.org/article/29586d4ccc924b56b3918d360dea53f42017-07-01T00:00:00Zhttps://doi.org/10.1038/s41531-017-0027-zhttps://doaj.org/toc/2373-8057Abstract Chronic insomnia is common in patients with Parkinson’s disease. There are limited data to guide its treatment in this patient population, especially in regards to non-pharmacologic interventions, some of which are highly effective in the non-Parkinson’s disease population. The aim of this study is to describe a series of Parkinson’s disease patients who underwent cognitive behavioral therapy for insomnia (CBTi). Parkinson’s disease patients who had undergone a baseline and at least one follow-up CBTi session were identified. Electronic medical records and pre-treatment and post-treatment patient sleep diaries were reviewed. Sleep measures of interest included wake time after sleep onset, sleep efficiency, sleep onset latency, and total sleep time. Pre-treatment and post-treatment values were compared within subjects using paired t-test. Five patients were included. Patients attended an average of eight sessions of CBTi (range 5–12). Significant increases in sleep efficiency (p = 0.02) and decreases in number of awakenings per night (p = 0.02) were found. Our data provide preliminary evidence that cognitive behavioral therapy is an effective treatment for insomnia in Parkinson’s disease, and is well tolerated and well received by patients. Given the limited data supporting use of medications to treat chronic insomnia in Parkinson’s disease, combined with their risks, randomized trials to demonstrate the efficacy of CBTi in Parkinson’s disease are warranted.Meghan HumbertJames FindleyMaria Hernandez-ConLana M. ChahineNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 3, Iss 1, Pp 1-6 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurology. Diseases of the nervous system RC346-429 Meghan Humbert James Findley Maria Hernandez-Con Lana M. Chahine Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
description	Abstract Chronic insomnia is common in patients with Parkinson’s disease. There are limited data to guide its treatment in this patient population, especially in regards to non-pharmacologic interventions, some of which are highly effective in the non-Parkinson’s disease population. The aim of this study is to describe a series of Parkinson’s disease patients who underwent cognitive behavioral therapy for insomnia (CBTi). Parkinson’s disease patients who had undergone a baseline and at least one follow-up CBTi session were identified. Electronic medical records and pre-treatment and post-treatment patient sleep diaries were reviewed. Sleep measures of interest included wake time after sleep onset, sleep efficiency, sleep onset latency, and total sleep time. Pre-treatment and post-treatment values were compared within subjects using paired t-test. Five patients were included. Patients attended an average of eight sessions of CBTi (range 5–12). Significant increases in sleep efficiency (p = 0.02) and decreases in number of awakenings per night (p = 0.02) were found. Our data provide preliminary evidence that cognitive behavioral therapy is an effective treatment for insomnia in Parkinson’s disease, and is well tolerated and well received by patients. Given the limited data supporting use of medications to treat chronic insomnia in Parkinson’s disease, combined with their risks, randomized trials to demonstrate the efficacy of CBTi in Parkinson’s disease are warranted.
format	article
author	Meghan Humbert James Findley Maria Hernandez-Con Lana M. Chahine
author_facet	Meghan Humbert James Findley Maria Hernandez-Con Lana M. Chahine
author_sort	Meghan Humbert
title	Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
title_short	Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
title_full	Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
title_fullStr	Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
title_full_unstemmed	Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series
title_sort	cognitive behavioral therapy for insomnia in parkinson’s disease: a case series
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/29586d4ccc924b56b3918d360dea53f4
work_keys_str_mv	AT meghanhumbert cognitivebehavioraltherapyforinsomniainparkinsonsdiseaseacaseseries AT jamesfindley cognitivebehavioraltherapyforinsomniainparkinsonsdiseaseacaseseries AT mariahernandezcon cognitivebehavioraltherapyforinsomniainparkinsonsdiseaseacaseseries AT lanamchahine cognitivebehavioraltherapyforinsomniainparkinsonsdiseaseacaseseries
_version_	1718387680755056640

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series

Ejemplares similares